| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y |
| P698 | PubMed publication ID | 10526277 |
| P50 | author | Gloria Encabo | Q55445994 |
| Enriqueta Felip | Q56605610 | ||
| Ramon Orriols | Q58354626 | ||
| P2093 | author name string | J Ferrer | |
| B Bermejo | |||
| Jaume Ferrer | |||
| Bego�a Bermejo | |||
| M A Villarino | |||
| Ma Antonia Villarino | |||
| S Vilà | |||
| Sara Vil� | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | 1488-1495 | |
| P577 | publication date | 1999-10-01 | |
| 1999-10-15 | |||
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions | |
| P478 | volume | 86 |
| Q44710948 | A novel immunoassay for the quantization of CYFRA 21-1 in human serum. |
| Q92278490 | Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma |
| Q37335377 | Biomarkers for malignant pleural mesothelioma: current status |
| Q33954818 | Clinical management of the patient with pleural effusion |
| Q84329932 | Diagnostic accuracy of tumour markers in serous effusions: a validation study |
| Q36464156 | Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions. |
| Q37006185 | Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. |
| Q43244893 | Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions |
| Q51670701 | Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4. |
| Q82146735 | Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients |
| Q54449968 | Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions. |
| Q53399960 | Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions. |
| Q88599780 | Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer |
| Q33730267 | Evaluation of two strategies for the interpretation of tumour markers in pleural effusions |
| Q34603299 | Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients |
| Q33813896 | Indiscriminate investigations have adverse effects |
| Q47653286 | Pleural MAC30 as a prognostic marker in NSCLC with malignant pleural effusion |
| Q39636689 | Pleural fluid analysis: standstill or a work in progress? |
| Q36169857 | Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results |
| Q37607314 | Pleural, peritoneal and pericardial effusions - a biochemical approach |
| Q37619567 | Reactive oxygen species modulator 1 (Romo1) as a novel diagnostic marker for lung cancer-related malignant effusion |
| Q81712074 | Squamous cell carcinoma antigen in lung cancer and nonmalignant respiratory diseases |
| Q43904159 | The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion. |
| Q41488931 | The risk factors of bone metastases in patients with lung cancer |
| Q35674214 | Useful clinical biological markers in diagnosis of pleural effusions in children |
| Q80858246 | [Diagnostic evaluation of pleural effusion] |
Search more.